AbCellera Biologics Inc (NAS:ABCL)
$ 8.01 -0.10 (-1.23%) Market Cap: 2.40 Bil Enterprise Value: 2.04 Bil PE Ratio: 0 PB Ratio: 2.59 GF Score: 56/100

Abcellera Biologics Inc at Bank of America Global Healthcare Conference Transcript

May 13, 2026 / 12:00 AM GMT
Release Date Price: $4.4 (-7.76%)


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ABCL.OQ - Abcellera Biologics Inc
Abcellera Biologics Inc at Bank of America Global Healthcare Conference
May 14, 2026 / 12:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Bank of America's annual healthcare conference in very toasty Las Vegas.

I'm very happy to be joined here on stage with Carl Hansen.

With Avcelra.

Thank you so much for joining.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
It's great to be here. Thanks for having me.

--------------------------------------------------------------------------------
Unidentified_1 [3]
--------------------------------------------------------------------------------
Wonderful. Maybe for those who might be newer to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot